Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
No open-market purchases or sales by Nuvectis Pharma, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Nuvectis Pharma, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 53 | 48 | −5 |
| Shares | 3.69M | 4.24M | +543.9K (+14.7%) |
| Value | $22.2M | $32.0M | +$9.79M (+44.0%) |
New holders (3)
Institutions that held Nuvectis Pharma, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CIBC Private Wealth Group, LLC | 14,574 | $110.0K | 0.00% |
| NBC Securities, Inc. | 3,000 | $22.6K | 0.00% |
| Spire Wealth Management | 300 | $2.27K | 0.00% |
Sold out (8)
Institutions that held Nuvectis Pharma, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Renaissance Technologies LLC | 42,800 | $257.7K |
| Jane Street Group, LLC | 26,278 | $158.2K |
| Gsa Capital Partners LLP | 23,450 | $141.0K |
| Two Sigma Investments, LP | 18,435 | $111.0K |
| XTX Topco Ltd | 14,866 | $89.5K |
| Marshall Wace, LLP | 10,693 | $64.4K |
| EverSource Wealth Advisors, LLC | 76 | $458 |
| SRS Capital Advisors, Inc. | 38 | $229 |